Radiology residents around the world typically record experiential learning (EL) in a clinical logbook, but according to a new study published in the Journal of Digital Imaging, modern PACS and RIS technology could very well be used to build the EL portfolios of the future.

The United States ranks as the only developed nation on a list of countries with increasing maternal mortality rates. No. 1 in spending at $3.3 trillion, the U.S. ranks 47th in pregnancy-related deaths and is one of only eight nations with worsening pregnancy-related death rates.

A New York radiologist has been suspended from his position at Montefiore Medical Center in the Bronx following allegations that he’s a white supremacist, Newsweek has reported.

The International Telecommunication Union (ITU) and World Health Organization (WHO) are converging for the global expansion of the use of artificial intelligence (AI) “to advance health for all worldwide.”

The FDA has approved a magnetic device system used for guiding sentinel lymph node biopsies in breast cancer patients undergoing a mastectomy. The solution, Sentimag, is manufactured by U.K.-based Endomag.

Cancer screening rates in the United States over the last 15 years fall short of national targets, according to new research from the Centers for Disease Control and Prevention (CDC).

The Medical Imaging & Technology Alliance (MITA) voiced its support for the U.S. House of Representative’s vote to repeal the 2.3 percent medical device tax and called on the Senate to follow suit.

Considering the growing threat of ransomware in healthcare, organizations need to plan for the day their data become hostages, according to new research from Marshall University. Training and maintaining “digital hygiene” can not only reduce the likelihood of an attack, it also may reduce the financial and operational impacts of an incident.

A team of international scientists developed a new non-invasive MRI-based early warning system that may alert physicians about approaching heart attacks in patients and identify those at high risk.

Depressive patients who took escitalopram after acute coronary syndrome (ACS)-related events had lower reoccurrences of major adverse cardiac events after eight years of follow-up, a group of Korean researchers reported in the Journal of the American Heart Association.